AAV vector vs. Lentiviral vectors for gene therapy

Scroll Down

Viral vectors are effective and efficient tools for gene therapy, transducing and delivering genes to target cell populations and achieving sustainable expression. The efficacy of a gene therapy is heavily dependent on the delivery vehicle chosen.

The most popular vectors for gene therapy are derived from adeno-associated viral vectors (AAV vectors) and lentiviral vectors. Both vectors can induce gene expression and cause limited immune response in the host.

AAV and lentiviral vector platforms offer their own unique pros and cons that could influence the viability and success of the gene therapy program chosen. With extensive expertise, Genezen understands the importance of making the right viral vector choice.

For insight into which viral vector could be best suited for your next gene therapy project, download our AAV vs. LV vector comparative overview by completing the form to the right.

You may also be interested in...

Genezen completes cGMP-lentiviral and retroviral vector…

Genezen, a cell and gene therapy Contract Development and Manufacturing Organization...

Read more

Genezen announces launch of Scientific Advisory…

Leading experts in cell and gene therapy will provide guidance to...

Read more

Overcoming development and manufacturing challenges with…

As efficient and effective tools for gene transduction and delivering genes...

Read more

Retroviruses in CAR-T therapies: From gamma…

Introduction In recent years, chimeric antigen receptor T (CAR-T) cells have...

Read more